Drug correction of endothelial dysfunction in children with chronic pyelonephritis

Drug correction of endothelial dysfunction in children with chronic pyelonephritis

Background. Timely and sufficient drug correction of endothelial dysfunction in children with chronic pyelonephritis determines the effectiveness of preventing its progression, improves cardiovascular and renal prognosis. The purpose of the study was to examine the effectiveness of various regimens...

Full description

Bibliographic Details
Main Author:	L.I. Vakulenko
Format:	Article
Language:	English
Published:	Zaslavsky O.Yu. 2018-10-01
Series:	Zdorovʹe Rebenka
Subjects:	endothelial dysfunction chronic pyelonephritis children angiotensin-converting enzyme inhibitors L-arginine
Online Access:	http://childshealth.zaslavsky.com.ua/article/view/148919

Similar Items

Endothelial dysfunction in children with pyelonephritis
by: O. Ye. Abaturov, et al.
Published: (2019-07-01)

Renal dysfunction in patients with chronic toxic hepatitis and ways of its correction
by: O. Kvasnytska, et al.
Published: (2023-05-01)

Blockade of Rennin-Angiotensin system blunts the fibrotic response in experimental acute pyelonephritis
by: Singal A, et al.
Published: (2005-01-01)

Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape
by: Francesca Fortini, et al.
Published: (2021-08-01)

Autonomic status in children with chronic pyelonephritis at the initial stages of chronic kidney disease
by: L.I. Vakulenko
Published: (2019-03-01)

Association of urinary 90 kDa angiotensin- converting enzyme with family history of hypertension and endothelial function in normotensive individuals
by: A.M.S. Teixeira, et al.
Published: (2008-05-01)

PREDICTORS OF PROGRESSION OF CHRONIC PYELONEPHRITIS IN CHILDREN
by: O. V. Lavrenchuk, et al.
Published: (2016-12-01)

Xanthogranulomatous pyelonephritis with nephrocutaneous fistula
by: Sachit Anand, et al.
Published: (2021-01-01)

Ultrasonic Density of Kidneys in Healthy Children and Children with Pyelonephritis
by: L.I. Vakulenko, et al.
Published: (2014-04-01)

Endothelial Dysfunction in SARS-CoV-2 Infection
by: Francesco Nappi, et al.
Published: (2022-03-01)

Renal dysfunction in patients with cardiovascular disease. The effects of blockers of the renin-angiotensinaldosterone system
by: T. N Zvereva, et al.
Published: (2016-03-01)

Empirical Therapy of Complicated Pyelonephritis
by: V. A. Beloborodov, et al.
Published: (2019-11-01)

Angiotensin converting enzyme inhibitors /
by: DeBrue, Anne N.
Published: (c200)

The role of endothelial dysfunction in the development of clinical manifestations of climacteric syndrome in premenopausal women
by: О. В. Занько, et al.
Published: (2017-10-01)

ENDOTHELIAL DYSFUNCTION AND ITS MANAGEMENT IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION COMBINED WITH METABOLIC SYNDROME
by: I. O. Yastremska
Published: (2021-05-01)

PECULIARITIES OF PRODUCTION OF SECRETORY LEUCOCYTE PROTEINASE INHIBITOR IN CHILDREN WITH ACUTE OR CHRONIC PYELONEPHRITIS
by: O. Lavrenchuk, et al.
Published: (2014-08-01)

ENDOTHELIAL DYSFUNCTION AS CORNERSTONE OF CARDIOVASCULAR EVENTS: MOLECULAR AND PHARMACEUTIC ASPECTS
by: V. V. Kireeva, et al.
Published: (2014-10-01)

CYTOKINES IN THE DIAGNOSIS OF THE SEVERITY OF THE ACTIVE PHASE OF CHRONIC PYELONEPHRITIS
by: D. G. Korenkov, et al.
Published: (2017-10-01)

Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular Protection
by: Monica Locatelli, et al.
Published: (2023-11-01)

ROLE OF HUMAN DISKOIDIN DOMAIN RECEPTOR 1 IN THE PROGRESSION OF CHRONIC PYELONEPHRITIS IN CHILDREN
by: N. N. Kaladze, et al.
Published: (2017-12-01)

Serum angiotensin converting enzyme in pemphigus vulgaris
by: Reza M Robati, et al.
Published: (2014-01-01)

Effect of Angiotensin Receptor Inhibitors on Endothelial Dysfunction
by: Alaleh Gheisari, et al.
Published: (2011-10-01)

Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19
by: Tatsuya Maruhashi, et al.
Published: (2021-05-01)

Impact of long-term antihypertensive therapy on the vasoregulating function of the brachial artery in patients with arterialhypertension associated with type 2 diabetes mellitus
by: R S Karpov, et al.
Published: (2003-11-01)

Clinicopathological spectrum of xanthogranulomatous pyelonephritis; a single-center experience over 7 years
by: Manish Jain, et al.
Published: (2022-07-01)

Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension
by: Pasquale Ambrosino, et al.
Published: (2022-04-01)

Comparative characteristics of inducible NO synthase inhibitor and nitric oxide donor in endothelial dysfunction correction caused by osteoarthrosis under experimental conditions
by: K. S. Orel, et al.
Published: (2019-01-01)

Bilateral emphysematous pyelonephritis
by: Caitlyn Hollingshead, et al.
Published: (2021-01-01)

Bacteriological investigation of pyelonephritis in AL-Najaf Governorate, Iraq: a cross-Sectional study
by: Al-janabi Dhafer Rahman Abed, et al.
Published: (2024-01-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Development of novel arginase inhibitors for therapy of endothelial dysfunction
by: Jochen eSteppan, et al.
Published: (2013-09-01)

Antecedent Administration of Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID‐19 Syndrome
by: Alberto Palazzuoli, et al.
Published: (2020-11-01)

Urinary Cytokines Spectrum of Different Etiologic and Pathogenic Types at Children with Chronic Pyelonephritis
by: Utz I.A., et al.
Published: (2011-12-01)

Chronic pyelonephritis in pregnancy
by: Dubrovskaya М.V., et al.
Published: (2012-12-01)

Angiotensin II and COVID-19. Secrets of interactions
by: A. O. Konradi, et al.
Published: (2020-05-01)

Angiotensin-converting Enzyme Inhibitors: Can it be a Potential Treatment of Infantile Hemangioma
by: Archika Gupta, et al.
Published: (2021-01-01)

Dynamics of endothelial and inducible synthase nitric oxide in experimental osteoarthritis and its correction
by: I. V. Savytskyi, et al.
Published: (2018-11-01)

MICROBIOCENOSIS IN CHILDREN WHITH CHRONIC RECURRENT PYELONEPHRITIS.
by: О. Lavrenchuk
Published: (2014-04-01)

Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project
by: Ghassan Bandak, et al.
Published: (2017-07-01)

Role of Renin-Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1–7
by: Gabriela M. Silva, et al.
Published: (2020-09-01)